within Pharmacolibrary.Drugs.S_SensoryOrgans.S01J_DiagnosticAgents.S01JA02_RoseBengalSodium;

model RoseBengalSodium
  extends Pharmacolibrary.Drugs.ATC.S.S01JA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01JA02</td></tr><td>route:</td><td>ocular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Rose bengal sodium is a synthetic xanthene dye, primarily used as a diagnostic staining agent in ophthalmology for evaluating eye surface damage and dry eye, and has also been investigated as a therapeutic agent for certain cancers (e.g., metastatic melanoma) under the name PV-10. It is mainly approved as a diagnostic ocular agent and is not an approved systemic therapeutic drug.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data for rose bengal sodium as an ophthalmic agent in humans. Estimates based on general physicochemical and use characteristics.</p><h4>References</h4><ol><li><p>Singh, JK, et al., &amp; Chell, PB (2004). The use of dye in ophthalmology. <i>The Journal of audiovisual media in medicine</i> 27(2) 62–67. DOI:<a href=\"https://doi.org/10.1080/01405110410001711454\">10.1080/01405110410001711454</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15223583/\">https://pubmed.ncbi.nlm.nih.gov/15223583</a></p></li><li><p>Toda, I, et al., &amp; Tsubota, K (1996). Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren&#x27;s syndrome. <i>Cornea</i> 15(2) 120–128. DOI:<a href=\"https://doi.org/10.1097/00003226-199603000-00003\">10.1097/00003226-199603000-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8925658/\">https://pubmed.ncbi.nlm.nih.gov/8925658</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end RoseBengalSodium;
